|
EMA Calls for Documentation of Biologic Manufacturing Processes
Drugmakers seeking approval for biologics trials in the EU must describe and justify their manufacturing processes and process controls, ideally with a flow chart of all steps, the European Medicines Agency (EMA) says.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives